Cleared Traditional

K223027 - NeuroTrigger Basic (NTB)

K223027 is an FDA 510(k) clearance for NeuroTrigger Basic (NTB), manufactured by Neurotrigger. The device is a Class 2 Physical Medicine device with product code IPF cleared through the Traditional 510(k) pathway after a 376-day FDA review.

K223027 · Neurotrigger · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2023
Decision
376d
Days
Class 2
Risk

K223027 is an FDA 510(k) clearance for the NeuroTrigger Basic (NTB). Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by Neurotrigger (Tel Aviv, IL). The FDA issued a Cleared decision on October 10, 2023 after a review of 376 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurotrigger devices

FDA 510(k) Submission Details - K223027

510(k) Number K223027 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2022
Decision Date October 10, 2023
Days to Decision 376 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
261d slower than avg
Panel avg: 115d · This submission: 376d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IPF Device Classification - Class 2, Special Controls

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 165
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K223027.
BTL-899M
K232937 · BTL Industries, Inc. · Dec 2023
Stim2Go
K230701 · PAJUNK GmbH Medizintechnologie · Nov 2023
Combo Electrotherapy Device
K231440 · Shenzhen Roundwhale Technology Co. , Ltd. · Nov 2023
accufit
K223802 · Mettler Electronics Corporation · Oct 2023
StarFormer, TightWave
K221274 · Fotona D.O.O. · Sep 2023
BACK 4
K230167 · Swims America Corp · Sep 2023